BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 19606239)

  • 1. Prostasin, a potential tumor marker in ovarian cancer--a pilot study.
    Costa FP; Batista EL; Zelmanowicz A; Svedman C; Devenz G; Alves S; Silva AS; Garicochea B
    Clinics (Sao Paulo); 2009; 64(7):641-4. PubMed ID: 19606239
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prostasin, a potential serum marker for ovarian cancer: identification through microarray technology.
    Mok SC; Chao J; Skates S; Wong K; Yiu GK; Muto MG; Berkowitz RS; Cramer DW
    J Natl Cancer Inst; 2001 Oct; 93(19):1458-64. PubMed ID: 11584061
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The serine protease prostasin (PRSS8) is a potential biomarker for early detection of ovarian cancer.
    Tamir A; Gangadharan A; Balwani S; Tanaka T; Patel U; Hassan A; Benke S; Agas A; D'Agostino J; Shin D; Yoon S; Goy A; Pecora A; Suh KS
    J Ovarian Res; 2016 Mar; 9():20. PubMed ID: 27036110
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Down-regulation of prostasin serine protease: a potential invasion suppressor in prostate cancer.
    Chen LM; Hodge GB; Guarda LA; Welch JL; Greenberg NM; Chai KX
    Prostate; 2001 Jul; 48(2):93-103. PubMed ID: 11433419
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of the sensitivity and specificity of serum level of prostasin, CA125, LDH, AFP, and hCG+β in epithelial ovarian cancer patients.
    Bastani A; Asghary A; Heidari MH; Karimi-Busheri F
    Eur J Gynaecol Oncol; 2017; 38(3):418-424. PubMed ID: 29693884
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PSP94, an upstream signaling mediator of prostasin found highly elevated in ovarian cancer.
    Ma JX; Yan BX; Zhang J; Jiang BH; Guo Y; Riedel H; Mueller MD; Remick SC; Yu JJ
    Cell Death Dis; 2014 Sep; 5(9):e1407. PubMed ID: 25188517
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of prostasin expression and function in the prostate.
    Chen LM; Zhang X; Chai KX
    Prostate; 2004 Apr; 59(1):1-12. PubMed ID: 14991861
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prostasin may contribute to chemoresistance, repress cancer cells in ovarian cancer, and is involved in the signaling pathways of CASP/PAK2-p34/actin.
    Yan BX; Ma JX; Zhang J; Guo Y; Mueller MD; Remick SC; Yu JJ
    Cell Death Dis; 2014 Jan; 5(1):e995. PubMed ID: 24434518
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Loss of prostasin (PRSS8) in human bladder transitional cell carcinoma cell lines is associated with epithelial-mesenchymal transition (EMT).
    Chen LM; Verity NJ; Chai KX
    BMC Cancer; 2009 Oct; 9():377. PubMed ID: 19849847
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Androgen regulation of prostasin gene expression is mediated by sterol-regulatory element-binding proteins and SLUG.
    Chen M; Chen LM; Chai KX
    Prostate; 2006 Jun; 66(9):911-20. PubMed ID: 16541421
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selection of potential markers for epithelial ovarian cancer with gene expression arrays and recursive descent partition analysis.
    Lu KH; Patterson AP; Wang L; Marquez RT; Atkinson EN; Baggerly KA; Ramoth LR; Rosen DG; Liu J; Hellstrom I; Smith D; Hartmann L; Fishman D; Berchuck A; Schmandt R; Whitaker R; Gershenson DM; Mills GB; Bast RC
    Clin Cancer Res; 2004 May; 10(10):3291-300. PubMed ID: 15161682
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prostasin serine protease inhibits breast cancer invasiveness and is transcriptionally regulated by promoter DNA methylation.
    Chen LM; Chai KX
    Int J Cancer; 2002 Jan; 97(3):323-9. PubMed ID: 11774283
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical significance of low expression of Prostasin mRNA in human gastric cancer.
    Sakashita K; Mimori K; Tanaka F; Tahara K; Inoue H; Sawada T; Ohira M; Hirakawa K; Mori M
    J Surg Oncol; 2008 Dec; 98(7):559-64. PubMed ID: 18932242
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ibuprofen regulates the expression and function of membrane-associated serine proteases prostasin and matriptase.
    Chai AC; Robinson AL; Chai KX; Chen LM
    BMC Cancer; 2015 Dec; 15():1025. PubMed ID: 26715240
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Blood-borne RT-PCR assay for prostasin- specific transcripts to identify circulating prostate cells in cancer patients.
    Laribi A; Berteau P; Gala J; Eschwège P; Benoit G; Tombal B; Schmitt F; Loric S
    Eur Urol; 2001 Jan; 39(1):65-71. PubMed ID: 11173941
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overexpression of trophoblast cell surface antigen 2 as an independent marker for a poor prognosis and as a potential therapeutic target in epithelial ovarian carcinoma.
    Xu N; Zhang Z; Zhu J; Xu L; Li Y; Duan L; Mao Y; Li H
    Int J Exp Pathol; 2016 Apr; 97(2):150-8. PubMed ID: 27127000
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of prostasin and its inhibitors during colorectal cancer carcinogenesis.
    Selzer-Plon J; Bornholdt J; Friis S; Bisgaard HC; Lothe IM; Tveit KM; Kure EH; Vogel U; Vogel LK
    BMC Cancer; 2009 Jun; 9():201. PubMed ID: 19555470
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation of epithelial sodium channels by prostasin in Xenopus oocytes.
    Adachi M; Kitamura K; Miyoshi T; Narikiyo T; Iwashita K; Shiraishi N; Nonoguchi H; Tomita K
    J Am Soc Nephrol; 2001 Jun; 12(6):1114-1121. PubMed ID: 11373334
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gene expression profiles in primary ovarian serous papillary tumors and normal ovarian epithelium: identification of candidate molecular markers for ovarian cancer diagnosis and therapy.
    Santin AD; Zhan F; Bellone S; Palmieri M; Cane S; Bignotti E; Anfossi S; Gokden M; Dunn D; Roman JJ; O'Brien TJ; Tian E; Cannon MJ; Shaughnessy J; Pecorelli S
    Int J Cancer; 2004 Oct; 112(1):14-25. PubMed ID: 15305371
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sodium absorption stimulator prostasin (PRSS8) has an anti-inflammatory effect via downregulation of TLR4 signaling in inflammatory bowel disease.
    Sugitani Y; Nishida A; Inatomi O; Ohno M; Imai T; Kawahara M; Kitamura K; Andoh A
    J Gastroenterol; 2020 Apr; 55(4):408-417. PubMed ID: 31916038
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.